- Home
- RNAC vs HCAT Comparison
RNAC vs HCAT Comparison
Compare RNAC & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- HCAT
- Stock Information
- Founded
- RNAC 2007
- HCAT 2008
- Country
- RNAC United States
- HCAT United States
- Employees
- RNAC N/A
- HCAT N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- HCAT Computer Software: Programming Data Processing
- Sector
- RNAC Health Care
- HCAT Technology
- Exchange
- RNAC Nasdaq
- HCAT Nasdaq
- Market Cap
- RNAC 242.4M
- HCAT 259.8M
- IPO Year
- RNAC 2016
- HCAT 2019
- Fundamental
- Price
- RNAC $9.92
- HCAT $3.60
- Analyst Decision
- RNAC Strong Buy
- HCAT Buy
- Analyst Count
- RNAC 6
- HCAT 11
- Target Price
- RNAC $41.25
- HCAT $8.00
- AVG Volume (30 Days)
- RNAC 65.3K
- HCAT 589.6K
- Earning Date
- RNAC 08-07-2025
- HCAT 08-06-2025
- Dividend Yield
- RNAC N/A
- HCAT N/A
- EPS Growth
- RNAC N/A
- HCAT N/A
- EPS
- RNAC N/A
- HCAT N/A
- Revenue
- RNAC $34,173,000.00
- HCAT $311,274,000.00
- Revenue This Year
- RNAC N/A
- HCAT $11.23
- Revenue Next Year
- RNAC N/A
- HCAT $9.71
- P/E Ratio
- RNAC N/A
- HCAT N/A
- Revenue Growth
- RNAC 31.91
- HCAT 4.88
- 52 Week Low
- RNAC $8.46
- HCAT $3.49
- 52 Week High
- RNAC $29.65
- HCAT $9.24
- Technical
- Relative Strength Index (RSI)
- RNAC 47.60
- HCAT 39.24
- Support Level
- RNAC $9.72
- HCAT $3.62
- Resistance Level
- RNAC $10.56
- HCAT $3.96
- Average True Range (ATR)
- RNAC 0.67
- HCAT 0.24
- MACD
- RNAC 0.07
- HCAT -0.03
- Stochastic Oscillator
- RNAC 42.91
- HCAT 8.11
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.